Non-Hodgkin's lymphoma of the head and neck: A 30-year experience at the university of Florida

Nathu, Rakesh M.; Mendenhall, Nancy P.; Almasri, Nidal M.; Lynch, James W.

doi:10.1002/(sici)1097-0347(199905)21:3<247::aid-hed10>3.0.co;2-6

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion5

Citation Types

Supporting

Mentioning

Contrasting

Unclassified

Year Published

2001

2018

Publication Types

Select...

Article6

Book3

Relationship

Self Cite0

Independent9

Authors

Journals

Cited by 62 publications

(22 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This incidence matches those of single-center retrospective studies published since 1986: 1.9 to 11.4 cases per year [2][3][4][5][6][7][8][9][10][11][12][13].…”

Section: Discussionmentioning

confidence: 99%

Extranodal lymphoma of the head and neck: A 67-case series

Picard

Cardinne

Denoux

et al. 2015

European Annals of Otorhinolaryngology, Head and Neck Diseases

View full text Add to dashboard Cite

show abstract

“…This incidence matches those of single-center retrospective studies published since 1986: 1.9 to 11.4 cases per year [2][3][4][5][6][7][8][9][10][11][12][13].…”

Section: Discussionmentioning

confidence: 99%

Extranodal lymphoma of the head and neck: A 67-case series

Picard

Cardinne

Denoux

et al. 2015

European Annals of Otorhinolaryngology, Head and Neck Diseases

View full text Add to dashboard Cite

show abstract

“…Other studies have also found size and stage of disease to be poor prognostic factors. 6,7,21 In our current series, WHO performance score 2, the presence of B-symptoms, tumor bulk [7 cm, and higher Ann Arbor stage were associated with inferior outcome (Table 2). On multivariate analysis, a performance score 2 and the presence of 'B' symptoms retained their poor prognostic significance (Table 3).…”

Section: Discussionmentioning

confidence: 99%

Primary diffuse large B‐cell lymphoma of the tonsil

Laskar

Bahl

Muckaden

et al. 2007

Cancer

View full text Add to dashboard Cite

The combination of palladium complex (tBu3P)Pd(Me)Cl (1) and NaB[3,5‐(CF3)2C6H3]4 (NaBAr4) catalyzed homopolymerization of a novel monomer, norbornene (NB) with a pendent 2‐fluorosulfonyltetrafluoroethoxymethyl chain (NBSF). Catalytic activities of 1/NaBAr4 were higher than those of previously reported palladium or nickel catalysts, probably, because the palladium center with electron donative tBu3P ligand was barely poisoned by the sulfonyl fluoride coordination. Thus, 1/NaBAr4 is the current best catalyst system for NBSF polymerization. The catalyst system also gave copolymers of NB with NBSF. The obtained copolymers have high sulfonyl‐fluoride incorporation and a narrow molecular weight distribution. Present catalyst system could control incorporation ratio of NBSF by changing a feed monomer ratio with slow addition of NB solution. © 2008 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 46: 5133–5141, 2008

show abstract

“…Fine needle aspiration biopsy gives an idea about the histology but an excision biopsy is the only way to reach an accurate defi nitive diagnosis [1,3,4,5]. In our case on FNAC a diagnosis of pleomorphic adenoma was given depending on which we carried out the excision.…”

Section: Discussionmentioning

confidence: 55%